Who Owns Yunnan Baiyao Group Company?

Yunnan Baiyao Group Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Controls Yunnan Baiyao?

Unraveling the ownership of a company is crucial for investors and strategists alike. Yunnan Baiyao, a leading Chinese pharmaceutical company, presents a fascinating case study in corporate governance. Understanding Yunnan Baiyao Group SWOT Analysis is the first step in understanding the company's position in the market. This exploration dives deep into the company's ownership structure, from its origins to its current status as a publicly traded entity.

Since its inception in 1902, Yunnan Baiyao has transformed significantly, evolving from a state-owned enterprise to a publicly traded corporation. This evolution has shaped the company's strategic direction and influenced its financial performance. Examining the current Yunnan Baiyao ownership structure, including key shareholders and the role of the state, provides valuable insights into its future. Understanding who owns Yunnan Baiyao is critical for anyone interested in the Chinese pharmaceutical market.

The story of Yunnan Baiyao begins with Qu Huanzhang, who developed the medicinal formula in 1902. This marked the genesis of what would become a significant Chinese pharmaceutical company. Early efforts included Qu Huanzhang registering a trademark in 1935, an early step in protecting his intellectual property.

Following Qu Huanzhang's death, his wife, Liao Lanying, made a pivotal decision. She donated the secret prescription for Yunnan Baiyao to the Chinese government in 1956. This act set the stage for the medicine's large-scale production and the company's evolution.

This transition highlights the shift in ownership and control, which is key to understanding the current Yunnan Baiyao ownership structure. It also illustrates the company's journey from a family-run business to a state-owned enterprise.

Early Ownership and Evolution

The company officially became a state-owned enterprise (SOE) in the 1960s, solidifying its place within the Chinese economic system. In 1971, the Yunnan provincial government established the Yunnan Baiyao Factory in Kunming to facilitate mass production. This move was a significant change, transforming the company from a private entity to one controlled by the government.

• Qu Huanzhang developed Yunnan Baiyao in 1902.
• The trademark was registered in 1935.
• The secret prescription was donated to the government in 1956.
• The Yunnan Baiyao Factory was established in 1971.

Yunnan Baiyao Group SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of Yunnan Baiyao has evolved significantly since its listing on the Shenzhen Stock Exchange (SZSE: 000538) on December 15, 1993. Initially, the state maintained dominant control, acting as the largest shareholder of both Yunnan Baiyao Group and Yunnan Baiyao Holdings. However, the company has undergone mixed-ownership reforms in recent years, leading to changes in its major shareholders and overall ownership distribution. These reforms have aimed to improve efficiency and governance.

Key events have shaped Yunnan Baiyao's ownership. A major shift occurred in March 2017 when Newhuadu Industrial Group acquired a significant stake. This was followed by a combined sale of a 10% stake by Newhuadu and the provincial government to Yuyue Technology Development in June of the same year. These transactions reduced the ownership held by government-controlled entities. As of 2024, a substantial portion of the shares is held by individual investors and private companies. This evolution reflects a move towards a more diversified ownership model.

Institutional investors also play a role in the Yunnan Baiyao ownership structure. As of April 30, 2025, there were 87 institutional owners and shareholders holding a total of 8,215,760 shares. Notable institutional shareholders include Vanguard Total International Stock Index Fund Investor Shares (VGTSX), iShares Core MSCI Emerging Markets ETF (IEMG), and Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR). This indicates a strong interest from global investment firms in the Chinese pharmaceutical company.

Ownership Evolution

Understanding the Yunnan Baiyao ownership structure is essential for investors. The company has transitioned from state control to a mixed-ownership model. For more insights into the company's strategic direction, consider reading about the Growth Strategy of Yunnan Baiyao Group.

• Initial state control transitioned to mixed ownership.
• Significant stakes held by individual investors and private companies.
• Institutional investors hold a considerable portion of shares.
• The company's structure impacts its governance and strategy.

Yunnan Baiyao Group PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current CEO of Yunnan Baiyao Group Co., Ltd. is Mr. Ming Dong, who was appointed in March 2021. His tenure is approximately 4.25 years. Mr. Dong's direct ownership in the company is 0.001%, with shares valued at around CN¥748.90K. The average tenure of the management team is 3.4 years, while the board of directors has an average tenure of 2.6 years. Understanding the Brief History of Yunnan Baiyao Group can provide additional context to the company's structure.

The board of directors includes both executive and non-executive members. Some members represent major shareholders, while others serve as independent directors. For example, Mr. He Tao, who has been a senior vice president since August 2024, was nominated to be a non-executive Director for YNBY International Limited, a company where Yunnan Baiyao Group Co., Limited is the controlling shareholder. Recent board appointments were announced on June 13, 2025, and the annual general meeting was held on April 21, 2025.

The voting structure generally follows a one-share-one-vote principle for ordinary shares. Various proposals require an affirmative vote of a majority of ordinary shares present and voting at general meetings. The company's market value management system, approved by the Board of Directors on March 31, 2025, aims to enhance market value and ensure compliance.

Key Takeaways on Yunnan Baiyao Ownership

The Board of Directors includes a mix of executive, non-executive, and independent members, ensuring diverse perspectives. The CEO, Mr. Ming Dong, has been in the role since March 2021. The company's voting structure is primarily based on a one-share-one-vote system.

• The average tenure of the board is 2.6 years.
• The company held its annual general meeting on April 21, 2025.
• The market value management system was approved on March 31, 2025.

Yunnan Baiyao Group Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, the ownership structure of the Yunnan Baiyao Group has been evolving. The company has been undergoing mixed-ownership reforms, which involve state-owned entities reducing their controlling stakes while bringing in private investors. In February 2024, the company approved a proposal regarding the change of use and cancellation of repurchased shares. From August 6, 2024, to February 5, 2025, the State-owned Equity Management Company increased its holdings by 17,807,463 shares, representing 0.9980% of the total share capital, with a cumulative investment of RMB 950,379,399.02. This increase did not change the company's status of having no controlling shareholder or de facto controller.

The company has also focused on shareholder returns. For 2024, a total cash dividend of RMB 23.98 (tax inclusive) per 10 shares was distributed, totaling RMB 4,278,661,722.00, which represented 90.09% of the net profit attributable to shareholders. Furthermore, a special dividend of RMB 12.13 (tax inclusive) for every 10 shares was distributed in November 2024. These actions reflect a commitment to rewarding shareholders amidst the ongoing evolution of the Yunnan Baiyao ownership structure.

The trend of institutional ownership is increasing, with 87 institutional owners holding shares as of April 2025. Additionally, the Chinese pharmaceutical company continues to diversify its business. This includes expanding into areas such as e-commerce trading and distributing its products to overseas markets through entities like YNBY International Limited, where the Baiyao Group is the controlling shareholder. For further insights into the competitive environment, you can explore the Competitors Landscape of Yunnan Baiyao Group.

Shareholder Returns

Yunnan Baiyao distributed a total cash dividend of RMB 23.98 (tax inclusive) per 10 shares for 2024. A special dividend of RMB 12.13 (tax inclusive) for every 10 shares was also distributed in November 2024.

Ownership Structure

Ongoing mixed-ownership reforms involve state-owned entities reducing stakes and introducing private investors. The State-owned Equity Management Company increased its holdings between August 2024 and February 2025.

Institutional Ownership

As of April 2025, 87 institutional owners hold shares in Yunnan Baiyao. This indicates growing interest from institutional investors.

Business Expansion

The company is expanding into e-commerce and international markets. YNBY International Limited, where Yunnan Baiyao Group is the controlling shareholder, facilitates overseas distribution.

Yunnan Baiyao Group Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs